Acquired Company

Seattle Project Corp completed the acquisition of substantially all of the assets of Gritstone bio, Inc. on December 30, 2024.

Gritstone bio, Inc., a clinical-stage biotechnology company, is dedicated to developing tumor-specific cancer immunotherapies to combat various types of cancer and infectious diseases. The company is headquartered in Emeryville, California. Show more

5959 HORTON STREET, EMERYVILLE, CA, UNITED STATES, 94608, California, 94608-2006, USA

BIOTECHNOLOGY

HEALTHCARE

Market Cap

3.803M

52 Wk Range

$0.00 - $0.00

Previous Close

$0.03

Open

$0.03

Volume

N/A

Day Range

$0.03 - $0.03

Enterprise Value

0.00

Cash

52.17M

Avg Qtr Burn

-26.81M

Insider Ownership

1.91%

Institutional Own.

29.03%

Qtr Updated

06/30/24

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GRANITE Details Solid tumor/s, Colorectal cancer , Gastric cancer, Cancer	Phase 2/3 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
samRNA Details COVID-19, Infectious disease	Phase 2b Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
SLATE Details Colorectal cancer , Lung cancer, Solid tumor/s, Cancer	Phase 2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.